GTBP · GT Biopharma, Inc.
$0.32
-0.01 (-2.61%)
At close · Aug 5
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2025, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$11.45M
Shares
36.06M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-05-28 | New | Biotechnology | $20,000,000 | $0 | 06b |
| 2025-05-27 | New | Biotechnology | $5,950,000 | $5,950,000 | 06b |
| 2025-03-07 | New | Biotechnology | $1,280,358 | $1,280,358 | 06b |
| 2020-07-23 | Amendment | Biotechnology | Indefinite | $5,607,000 | 06b |
| 2020-06-12 | New | Biotechnology | Indefinite | $2,417,000 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
109657
CUSIP
36254L308
13F (30d)
18 filings
18 filers
Visit website
Investor relations